Skip to main content

TCG — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

147
Companies
$1.7B
Total invested
$26.4M
Avg. check
42
Industries
Biotechnology 12Health Care 9Therapeutics 8Medical 7Pharmaceutical 7Biopharma 6+36 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 147
Glass
September 2022

Glass is a video platform that enables creators to earn NFTs from their videos.

Content Creators · Los Angeles$5.0M Seed
Vicebio
September 2024

Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.

Biotechnology · London$100.0M Series B
Hume
September 2022

Hume provides a web3 record label creating music-driven metastars.

Information Technology · Los Angeles$11.7M Series A
Immortal Game
September 2022

Immortal Game Play-and-Earn. Free-to-Play. Immortal Game introduces a new layer of strategy to the most played board game in the world.

Blockchain · Paris$12.2M Series A
Allakos
September 2022

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Biopharma · Redwood City$150.0M Post-IPO Equity
RayzeBio
September 2022

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

Biotechnology · San Diego$160.0M Series D
Korsana Biosciences
September 2025

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Biopharma · Waltham$150.0M Series A
Versanis Bio
August 2021

Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.

Biotechnology · Oakland$70.0M Series A
Plexium
August 2025

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Biotechnology · San Diego$60.1M Series C
Better Place Forests
August 2023

Better Place Forests provides memorial spreading forests for families who choose cremation.

Family · San Francisco$7.8M Venture - Series Unknown
Pathalys Pharma
August 2024

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Biopharma · Raleigh$105.0M Series B
LB Pharmaceuticals
July 2026

LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.

Biopharma · New York$150.0M Post-IPO Equity
Headspace
July 2023

Headspace is a mental health company offering AI companionship, coaching, therapy, psychiatry, and mindfulness tools for everyday support.

Artificial Intelligence (AI) · Santa Monica$105.0M Debt Financing
Virtually Human Studio
July 2021

Decentralised Entertainment

Blockchain · Oakleigh$20.0M Series A
Jia
July 2026

Jia provides blockchain-based financing to businesses in emerging markets and delivers returns on real-world assets to investors.

Banking · Los Angeles$2.0M Debt Financing
Arkive
July 2022

Arkive is redefining culture by building the first-ever decentralized physical museum.

Internet · Santa Monica$9.7M Seed
Tribute Brand
July 2022

The world's first D2C digital fashion brand & tech house, producing 3D & AR/VR assets for apps, gaming and the metaverse.

E-Commerce · Zagreb$4.5M Seed
Upstream Bio
June 2023

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Biotechnology · Waltham$200.0M Series B
Mineralys Therapeutics
June 2026

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Biopharma · Radnor$500.0M Post-IPO Debt
Premier Lacrosse League
June 2026

Premier Lacrosse League is a proposed professional lacrosse league.

E-Commerce · New York$100.0M Series E
Ollin Biosciences
June 2026

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

Biopharma · Austin$330.0M Series B
Entrada Therapeutics
June 2024

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Biotechnology · Boston$100.0M Post-IPO Equity
Unrivaled Sports
May 2025

Unrivaled Sports manages a diverse portfolio of youth sports properties in Baseball, Softball, Football, and Action Sports.

American Football · New York$120.0M Venture - Series Unknown
Abivax
May 2026

Abivax develops medicines that alter the body's natural immune system mechanisms.

Biotechnology · Paris$45.0M Post-IPO Equity

Where TCG invests

Biotechnology12
Health Care9
Therapeutics8
Medical7
Pharmaceutical7
Biopharma6

About TCG's portfolio

How many companies has TCG invested in?

TCG has invested in 147 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does TCG invest in?

TCG's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 42 different industry categories.

What is TCG's largest investment?

Among tracked funding rounds, Mineralys Therapeutics received $500.0M in a Post-IPO Debt round. TCG's total known invested capital is $1.7B.

What is the average investment size for TCG?

TCG's average investment size is $26.4M across its portfolio of 147 companies.

What are TCG's most recent investments?

Recent TCG portfolio additions include Glass, Vicebio, Hume, Immortal Game, Allakos. These companies were founded in 2020 or later.

Reach the founders behind these 147 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →